ARTICLE | Company News
Ethypharm, Gruenenthal sales and marketing update
March 18, 2013 7:00 AM UTC
Ethypharm granted Gruenenthal an exclusive license to commercialize Ethypharm's fentanyl sublingual tablets in selected EU countries to treat breakthrough cancer pain. The countries include France, th...